Monday, October 26, 2026 · Daily editionET --:--:--

Looking for volunteers

HUGO-SLEEVE: Evaluating the Feasibility of Robotic Sleeve Gastrectomy With a New Platform

NCT07884994 · Universitätsklinikum Hamburg-Eppendorf · Updated 21 Oct 2026

What is being tested
Sleeve Gastrectomy using Hugo RAS platform
For
Obesity (BMI > 35); Obesity (BMI > 35) and Diabetes Mellitus; Obesity (BMI > 35) and Dyslipemia; Obesity (BMI > 35) and High Blood Pressure
Kind of study
Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
Who can join
Ages 18 years and older. About 50 people. The full rules are on the registry page.
Where
Germany
When
Starts or started 4 June 2026, ends 31 Dec 2027. Registered 21 Oct 2026.
Results
None posted yet.

In the researchers' words

Severe obesity is a chronic condition that can lead to a range of serious health problems. One common treatment option is sleeve gastrectomy, a weight-loss operation in which the size of the stomach is reduced. These procedures are increasingly being performed with the support of robotic surgical systems. However, there is still limited clinical experience with the Hugo™ Robotic-Assisted Surgery System for this type of operation. The aim of this study is to evaluate whether sleeve gastrectomy can be performed safely and reliably using the Hugo™ system. In particular, the study will assess whether the operation can be completed as planned with the robotic system and will examine outcomes during and after surgery. The study will include 50 adults with severe obesity who are scheduled to undergo sleeve gastrectomy. Information will be collected during the operation, including the duration of different surgical steps and the occurrence of any complications. Participants will be followed for six months after surgery. During this period, information on pain, complications, hospital stays, readmissions, and quality of life will be collected. The study aims to provide important information about the safe introduction and use of the Hugo™ system for this established weight-loss procedure.
ClinicalTrials.gov, NCT07884994

Sites

  • University Medical Center Hamburg-EppendorfHamburg, Free and Hanseatic City of Hamburg, Germany